(Q34580293)

English

Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

cost–benefit analysis

1 reference

based on heuristic

inferred from title

cervix uterine cancer

1 reference

based on heuristic

inferred from title

7

object named as

Toos Daemen

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Maarten J. Postma

9

object named as

Maarten J Postma

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Tjalke A Westra

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Irina Stirbu-Wagner

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sara Dorsman

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Eric D Tutuhatunewa

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Edwin L de Vrij

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Hans W Nijman

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Jan C Wilschut

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

7 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

BMC Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

75

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

7 February 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575363

7 July 2018

Dynamic modeling for pandemic influenza

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575363

7 July 2018

Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575363

7 July 2018

Modelling the epidemiology of infectious diseases for decision analysis: a primer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575363

7 July 2018

Trends in sexually transmitted infections in the Netherlands, combining surveillance data from general practices and sexually transmitted infection centers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575363

7 July 2018

Cervical cancer prevention: new tools and old barriers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575363

7 July 2018

Efficacy of human papillomavirus vaccines: a systematic quantitative review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575363

7 July 2018

Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575363

7 July 2018

Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575363

7 July 2018

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575363

7 July 2018

Cost of treatment and QALYs lost due to genital warts: data for the economic evaluation of HPV vaccines in the United Kingdom

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575363

7 July 2018

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575363

7 July 2018

Sexual behaviour and HPV infections in 18 to 29 year old women in the pre-vaccine era in the Netherlands

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575363

7 July 2018

Economic evaluation of human papillomavirus vaccination in the United Kingdom

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575363

7 July 2018

Human papillomavirus and cervical cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-75

21 January 2018

Long-term impact of human papillomavirus vaccination on infection rates, cervical abnormalities, and cancer incidence

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-75

21 January 2018

Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-75

21 January 2018

Age-specific HPV seroprevalence among young females in The Netherlands.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-75

21 January 2018

Estimation of the impact of genital warts on health-related quality of life

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-75

21 January 2018

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-75

21 January 2018

Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: modeling of sustained antibody responses

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-75

21 January 2018

Cost-effectiveness analysis of the bivalent compared with the quadrivalent human papillomavirus vaccines in Taiwan

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-75

21 January 2018

Funding of drugs: do vaccines warrant a different approach?

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-13-75

21 January 2018

Distribution of human papillomavirus types in anogenital warts of men

1 reference

https://pubmed.ncbi.nlm.nih.gov/23390964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HPV vaccine strategies: the cost of HPV and the choice of vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/23390964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Until which age should women be vaccinated against HPV infection? Recommendation based on cost-effectiveness analyses

1 reference

https://pubmed.ncbi.nlm.nih.gov/23390964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylactic HPV vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/23390964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Efficiency of human papillomavirus vaccination--estimates based on Dutch cost effectiveness analyses]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23390964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types

1 reference

https://pubmed.ncbi.nlm.nih.gov/23390964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of prophylactic vaccination against human papillomavirus 16/18 for the prevention of cervical cancer: adaptation of an existing cohort model to the situation in the Netherlands

1 reference

https://pubmed.ncbi.nlm.nih.gov/23390964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HPV16/18 vaccination to prevent cervical cancer in The Netherlands: model-based cost-effectiveness

1 reference

https://pubmed.ncbi.nlm.nih.gov/23390964

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2334-13-75

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34580293&oldid=2196821771"